Research suggests that the available evidence directly examining myo-inositol for anxiety relief cannot be meaningfully summarized from the single study provided, as that study investigated orexin receptor signaling in dopamine neurons of mice and does not examine myo-inositol in any capacity. The linked study, which is an animal model investigation into neurological mechanisms relevant to ADHD, OCD, and autism spectrum disorder, offers no data on myo-inositol's effects on anxiety. As a result, no conclusions about myo-inositol and anxiety can be drawn from this evidence base. Readers interested in the research on myo-inositol for anxiety should seek studies that directly examine this compound, such as those investigating its role in serotonin signaling or clinical trials in populations with anxiety disorders.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Divergent modulation of dopaminergic neurons by hypocretin/orexin receptors-1... | Other | 2025 | Neutral | 85 |